Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2
NCT04479163
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
165
Enrollment
OTHER
Sponsor class
Conditions
COVID
Interventions
BIOLOGICAL:
Convalescent Plasma
OTHER:
Placebo
Sponsor
Fundacion Infant